(Q46878365)

26 December 2017

title

Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population (English)

1 reference

26 December 2017

0 references

Janez Tomazic

1

1 reference

26 December 2017

Katja Ul

2

1 reference

26 December 2017

Gabriele Volcansek

3

1 reference

26 December 2017

Samo Gorensek

4

1 reference

26 December 2017

Misa Pfeifer

5

1 reference

26 December 2017

Primoz Karner

6

1 reference

26 December 2017

Janez Prezelj

7

1 reference

26 December 2017

Gaj Vidmar

8

1 reference

26 December 2017

Ludvik Vidmar

9

1 reference

26 December 2017

publication date

1 January 2007

1 reference

26 December 2017

published in

Vienna Clinical Weekly

1 reference

26 December 2017

volume

119

1 reference

26 December 2017

issue

21-22

1 reference

26 December 2017

page(s)

639-646

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00508-007-0844-x

exact match

0 references

cites work

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Emerging bone problems in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Acute hepatic failure and lactate acidosis associated with antiretroviral treatment for HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Potential predictive factors of osteoporosis in HIV-positive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Severe Osteoporosis in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Diagnosis of osteoporosis in men, premenopausal women, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Bone disease and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Osteopenia and osteoporosis in patients with HIV: a review of current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

An Increased Risk of Osteoporosis during Acquired Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Osteopenia in HIV-infected women prior to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Bone mass in HIV-infected patients: focus on the role of therapy and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Reduced bone mineral density in HIV-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-007-0844-X

Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.

21 January 2018

1 reference

12 December 2020

Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system

1 reference

12 December 2020

BMD Is Reduced in HIV-Infected Men Irrespective of Treatment

1 reference

12 December 2020

Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy

1 reference

12 December 2020

Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy

1 reference

12 December 2020

Ten-year probabilities of clinical vertebral fractures according to phalangeal quantitative ultrasonography

1 reference

12 December 2020

Fragility Fractures in HIV-Infected Patients: Need for Better Understanding of Diagnosis and Management

1 reference

12 December 2020

Therapeutic management of bone demineralization in the HIV-infected population

1 reference

12 December 2020

10.1007/S00508-007-0844-X

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017